The efficacy of ustekinumab on the articular and dermatologic manifestations of psoriatic arthritis Arthur Kavanaugh Clinical Trials Report 18 August 2009 Pages: 233 - 234
What was wrong and might now go right with clinical trials for lupus? Joan T. Merrill Current Reports / Rheumatology / Invited Commentary 18 August 2009 Pages: 235 - 237
Atherosclerosis risk factors in systemic lupus erythematosus Surabhi AgarwalJennifer R. ElliottSusan Manzi OriginalPaper 18 August 2009 Pages: 241 - 247
Epidemiology of atherosclerosis in systemic lupus erythematosus Mandana NikpourMurray B. UrowitzDafna D. Gladman OriginalPaper 18 August 2009 Pages: 248 - 254
Effects of inflammation on cholesterol metabolism: Impact on systemic lupus erythematosus Allison B. Reiss OriginalPaper 18 August 2009 Pages: 255 - 260
Psoriatic arthritis: Pharmacoeconomic considerations Ignazio OlivieriLorenzo Giovanni MantovaniSimona de Portu OriginalPaper 18 August 2009 Pages: 263 - 269
Update on the treatment of peripheral arthritis in psoriatic arthritis Enrique R. SorianoJavier Rosa OriginalPaper 18 August 2009 Pages: 270 - 277
Assessment and treatment of psoriatic spondylitis Peter Nash OriginalPaper 18 August 2009 Pages: 278 - 283
Genetic risk and protective factors for the idiopathic inflammatory myopathies Terrance P. O’HanlonFrederick W. Miller OriginalPaper 18 August 2009 Pages: 287 - 294
The inflammatory milieu in idiopathic inflammatory myositis Ann M. ReedFloranne Ernste OriginalPaper 18 August 2009 Pages: 295 - 301
Ultrasound in the evaluation of the inflammatory myopathies Ronald S. AdlerGiovanna Garofalo OriginalPaper 18 August 2009 Pages: 302 - 308